{"id":19046,"date":"2024-02-28T11:36:42","date_gmt":"2024-02-28T11:36:42","guid":{"rendered":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/2024\/02\/28\/gen-ilac-genil-dev-sozlesmeyi-acikladi\/"},"modified":"2024-02-28T11:36:42","modified_gmt":"2024-02-28T11:36:42","slug":"gen-ilac-genil-dev-sozlesmeyi-acikladi","status":"publish","type":"post","link":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/2024\/02\/28\/gen-ilac-genil-dev-sozlesmeyi-acikladi\/","title":{"rendered":"Gen \u0130la\u00e7 (GENIL) dev s\u00f6zle\u015fmeyi a\u00e7\u0131klad\u0131!"},"content":{"rendered":"<p>Gen \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri Sanayi ve Ticaret A.\u015e.\u00a0(GENIL) taraf\u0131ndan 28 \u015eubat 2024 tarihinde Kamuyu Ayd\u0131nlatma Platformu\u2019na yap\u0131lan bildirimde GEN ile Recordati Grup \u015eirketleri Aras\u0131nda S\u00f6zle\u015fme \u0130mzalanmas\u0131 hakk\u0131nda a\u00e7\u0131klama yap\u0131ld\u0131.<\/p>\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" loading=\"lazy\" width=\"1024\" height=\"576\" src=\"https:\/\/rotaborsa.com\/wp-content\/uploads\/2023\/09\/borsa-large.jpg\" alt=\"| Rota Borsa\" class=\"wp-image-57186\" title=\"| Rota Borsa\" \/><\/figure>\n<p>A\u00e7\u0131klamada Gen \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri\u00a0Sanayi ve Ticaret A.\u015e. (\u201cGEN\u201d) ile Recordati Grup \u015eirketlerinden, EUSA Pharma\u00a0(UK) Limited, Recordati Rare Diseases, Recordati AG Rare Diseases Branch ve\u00a0Recofarma \u0130la\u00e7 ve Hammaddeleri Sanayi ve Ticaret Limited\u00a0\u015eirketi aras\u0131nda, 1\u00a0Mart 2024 tarihinden itibaren y\u00fcr\u00fcrl\u00fc\u011fe girmek \u00fczere m\u00fcnhas\u0131r distrib\u00fct\u00f6rl\u00fck\u00a0s\u00f6zle\u015fmesi (\u201cS\u00f6zle\u015fme\u201d) imzaland\u0131\u011f\u0131 belirtildi. S\u00f6z konusu S\u00f6zle\u015fmenin ve say\u0131lan\u00a0ila\u00e7lar\u0131n \u015eirketin 2024 y\u0131l\u0131 toplam sat\u0131\u015flar\u0131na katk\u0131s\u0131n\u0131n 500.000.000,00 TL\u2019nin\u00a0(Be\u015f Y\u00fcz Milyon T\u00fcrk Liras\u0131) \u00fczerinde olmas\u0131 beklendi\u011fi ifade edildi.<\/p>\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Gen \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri\u00a0Sanayi ve Ticaret A.\u015e. (\u201cGEN\u201d) ile Recordati Grup \u015eirketlerinden, EUSA Pharma\u00a0(UK) Limited, Recordati Rare Diseases, Recordati AG Rare Diseases Branch ve\u00a0Recofarma \u0130la\u00e7 ve Hammaddeleri Sanayi ve Ticaret Limited\u00a0\u015eirketi aras\u0131nda, 1\u00a0Mart 2024 tarihinden itibaren y\u00fcr\u00fcrl\u00fc\u011fe girmek \u00fczere m\u00fcnhas\u0131r distrib\u00fct\u00f6rl\u00fck\u00a0s\u00f6zle\u015fmesi (\u201cS\u00f6zle\u015fme\u201d) imzalanm\u0131\u015ft\u0131r. S\u00f6zle\u015fme, yenileme h\u00fck\u00fcmlerine de tabi\u00a0olmak \u00fczere, 1 Mart 2028 tarihine kadar y\u00fcr\u00fcrl\u00fckte kalacakt\u0131r.<\/p>\n<div class=\"kanews-banner kanews-banner-single\">\n<div style=\"min-height:280px\" data-empower-zone=\"159899\" class=\"empower-ad\"><\/div>\n<\/div>\n<p>Bu S\u00f6zle\u015fme ile GEN,\u00a0halihaz\u0131rda ithal etmekte oldu\u011fu, EUSA Pharma (UK) Limited\u2019e ait Qarziba adl\u0131\u00a0ilaca ek olarak, Cosmegen, Cystadane, Cystadrops, Cytagon, Normosang, Isturisa,\u00a0Carbaglu, Signifor adl\u0131 ila\u00e7lar\u0131n da T\u00fcrkiye\u2019ye ithali ve\u00a0T\u00fcrkiye\u2019de sat\u0131\u015f\u0131 ve\u00a0da\u011f\u0131t\u0131m\u0131 konusunda m\u00fcnhas\u0131ran yetkilendirilmi\u015f ve bu ila\u00e7lar i\u00e7in T\u00fcrkiye\u2019de\u00a0tek yetkili distrib\u00fct\u00f6r haline gelmi\u015ftir.<\/p>\n<p>B\u00f6ylece, Qarziba adl\u0131 ilaca ek\u00a0olarak \u015firketimizin ila\u00e7 portf\u00f6y\u00fcne 8 yeni ila\u00e7 daha dahil edilmi\u015ftir.<\/p>\n<p>S\u00f6z konusu S\u00f6zle\u015fmenin ve say\u0131lan\u00a0ila\u00e7lar\u0131n \u015eirketimizin 2024 y\u0131l\u0131 toplam sat\u0131\u015flar\u0131na katk\u0131s\u0131n\u0131n 500.000.000,00 TL\u2019nin\u00a0(Be\u015f Y\u00fcz Milyon T\u00fcrk Liras\u0131) \u00fczerinde olmas\u0131 beklenmektedir.<\/p>\n<p>\u0130\u015fbu a\u00e7\u0131klamam\u0131z\u0131n \u0130ngilizce\u00a0\u00e7evirisi ekte yer almakta olup T\u00fcrk\u00e7e ve \u0130ngilizce metin aras\u0131nda farkl\u0131l\u0131k\u00a0olmas\u0131 halinde T\u00fcrk\u00e7e a\u00e7\u0131klama metni esas kabul edilecektir.\u00a0<\/p>\n<\/blockquote>\n<p><strong><a href=\"https:\/\/t.me\/rotaborsa_halkaarz\" target=\"_blank\" rel=\"noreferrer noopener\"><strong><mark class=\"has-inline-color has-vivid-red-color\">Borsa ve halka arzlar ile ilgili geli\u015fmeleri en h\u0131zl\u0131 \u015fekilde \u00f6\u011frenmek ve Rotaborsa telegram hesab\u0131n\u0131 takip etmek i\u00e7in t\u0131klay\u0131n\u0131z.<\/mark><\/strong><\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gen \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri Sanayi ve Ticaret A.\u015e.\u00a0(GENIL) taraf\u0131ndan 28 \u015eubat 2024 tarihinde Kamuyu Ayd\u0131nlatma Platformu\u2019na yap\u0131lan bildirimde GEN ile Recordati Grup \u015eirketleri Aras\u0131nda S\u00f6zle\u015fme \u0130mzalanmas\u0131 hakk\u0131nda a\u00e7\u0131klama yap\u0131ld\u0131. A\u00e7\u0131klamada Gen \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri\u00a0Sanayi ve Ticaret A.\u015e. (\u201cGEN\u201d) ile Recordati Grup \u015eirketlerinden, EUSA Pharma\u00a0(UK) Limited, Recordati Rare Diseases, Recordati AG Rare Diseases Branch [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":19047,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-19046","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-borsa-haberleri"],"_links":{"self":[{"href":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/wp-json\/wp\/v2\/posts\/19046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/wp-json\/wp\/v2\/comments?post=19046"}],"version-history":[{"count":0,"href":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/wp-json\/wp\/v2\/posts\/19046\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/wp-json\/wp\/v2\/media\/19047"}],"wp:attachment":[{"href":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/wp-json\/wp\/v2\/media?parent=19046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/wp-json\/wp\/v2\/categories?post=19046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amazing-banzai.188-132-230-163.plesk.page\/index.php\/wp-json\/wp\/v2\/tags?post=19046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}